NCT07195916 2026-04-14A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesIncyte CorporationPhase 1 Recruiting280 enrolled
NCT02465060 2026-04-13Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)National Cancer Institute (NCI)Phase 2 Active not recruiting6,452 enrolled 2 FDA
NCT05334069 2026-04-07Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionAlliance for Clinical Trials in OncologyRecruiting2,000 enrolled
NCT06870487 2026-04-01A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersPfizerPhase 1 Active not recruiting6 enrolled